AstraZeneca PLC
AZN· NYSE
AZNAstraZeneca PLC
Source filing unavailable
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $8.22B | $6.28B | $5.82B | $5.16B |
| Net Income | $550.00M | $756.00M | $130.00M | $350.00M |
| EPS Diluted | $0.42 | $0.58 | $0.10 | $0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AstraZeneca PLC · CIK 901832 · Engraved from SEC EDGAR
